| Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern AA Gorchakov, SV Kulemzin, SV Guselnikov, KO Baranov, ... Cell Discovery 7 (1), 96, 2021 | 26 | 2021 |
| Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon Ex Vivo Restimulation MG Byazrova, SV Kulemzin, EA Astakhova, TN Belovezhets, GA Efimov, ... Frontiers in Immunology 13, 840707, 2022 | 22 | 2022 |
| Design and analysis of stably integrated reporters for inducible transgene expression in human T cells and CAR NK-cell lines SV Kulemzin, DA Matvienko, AH Sabirov, AM Sokratyan, DS Chernikova, ... BMC medical genomics 12, 87-95, 2019 | 22 | 2019 |
| shp-2 gene knockout upregulates CAR-driven cytotoxicity of YT NK cells VG Subrakova, SV Kulemzin, TN Belovezhets, AN Chikaev, NA Chikaev, ... Vavilov Journal of Genetics and Breeding 24 (1), 80, 2020 | 14 | 2020 |
| “Pulsed Hypoxia” Gradually Reprograms Breast Cancer Fibroblasts into Pro-Tumorigenic Cells via Mesenchymal–Epithelial Transition A Nushtaeva, M Ermakov, M Abdurakhmanova, O Troitskaya, ... International Journal of Molecular Sciences 24 (3), 2494, 2023 | 8 | 2023 |
| Highly invasive fluorescent/bioluminescent patient-derived orthotopic model of glioblastoma in mice D Yuzhakova, E Kiseleva, M Shirmanova, V Shcheslavskiy, D Sachkova, ... Frontiers in Oncology 12, 897839, 2022 | 5 | 2022 |
| Analysis of in vitro activity of PSCA-specific CARs in the context of human NK cell line YT DA Matvienko, SV Kulemzin, AS Smagina, TN Belovezhets, AN Chikaev, ... Cell Ther. Transplant 7, 70-76, 2018 | 5 | 2018 |
| A simple way to increase recovery of the expressed VH and VL genes in single-sorted human B cells SV Guselnikov, TN Belovezhets, SV Kulemzin, AA Gorchakov, AV Taranin BioTechniques 67 (4), 184-187, 2019 | 4 | 2019 |
| VH3-53/66-Class RBD-Specific Human Monoclonal Antibody iB20 Displays Cross-Neutralizing Activity against Emerging SARS-CoV-2 Lineages SV Kulemzin, MV Sergeeva, KO Baranov, AA Gorchakov, SV Guselnikov, ... Journal of Personalized Medicine 12 (6), 895, 2022 | 2 | 2022 |
| Memory B cell and humoral responses elicited by Sputnik V in naïve and COVID-19-recovered vaccine recipients MG Byazrova, SV Kulemzin, EA Astakhova, TN Belovezhets, GA Efimov, ... MedRxiv, 2021.10. 13.21264894, 2021 | 2 | 2021 |
| CAR-dependent anti-metastatic activity of modified NK cell line YT OA Koval, VG Subrakova, AA Nushtaeva, TN Belovezhets, OA Troitskaya, ... Genes & Cells 14 (4), 66-71, 2019 | 2 | 2019 |
| Analysis of in vitro cytotoxicity of human NK cell line co-expressing a PSMA-specific CAR and an antitumor agent lactaptin TN Belovezhets, DA Matvienko, OY Volkova, OAA Koval, AV Tkachenko, ... Genes & Cells 13 (3), 89-93, 2018 | 2 | 2018 |
| Humoral Immune Responses in Patients with Severe COVID-19: A Comparative Pilot Study between Individuals Infected by SARS-CoV-2 during the Wild-Type and the Delta Periods M Sukhova, M Byazrova, A Mikhailov, G Yusubalieva, I Maslova, ... Microorganisms 11 (9), 2347, 2023 | 1 | 2023 |
| Comparative Pre-Clinical Analysis of CD20-Specific CAR T Cells Encompassing 1F5-, Leu16-, and 2F2-Based Antigen-Recognition Moieties T Belovezhets, S Kulemzin, O Volkova, A Najakshin, A Taranin, ... International Journal of Molecular Sciences 24 (4), 3698, 2023 | 1 | 2023 |
| CAR-modified natural killer cell line expressing CD47/SIRPa blockers as a combined approach for solid cancer therapy A Chikaev, A Gorchakov, S Kulemzin, T Belovezhets, D Matvienko, ... Annals of Oncology 29, x12, 2018 | 1 | 2018 |
| ECAR-NK Cell Platform: Enhancing the CAR-Mediated NK Cell Cytotoxicity via Blockade of the CD47/SIRPa Axis A Gorchakov, AN Chikaev, SV Kulemzin, OY Volkova, DS Chernikova, ... MOLECULAR THERAPY 26 (5), 199-199, 2018 | 1 | 2018 |
| Serial Llama Immunization with Various SARS-CoV-2 RBD Variants Induces Broad Spectrum Virus-Neutralizing Nanobodies PP Solodkov, AM Najakshin, NA Chikaev, SV Kulemzin, LV Mechetina, ... Vaccines 12 (2), 129, 2024 | | 2024 |
| Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection SV Kulemzin, SV Guselnikov, BG Nekrasov, SV Molodykh, IN Kuvshinova, ... Vaccines 12 (1), 55, 2024 | | 2024 |
| Humoral Immune Responses in Patients with Severe COVID-19: A Comparative Study between Individuals Infected by SARS-CoV-2 during the Wild-Type and the Delta Periods MM Sukhova, M Byazrova, A Mikhailov, G Yusubalieva, IV Maslova, ... Preprints, 2023 | | 2023 |
| Corrigendum: Highly invasive fluorescent/bioluminescent patient-derived orthotopic model of glioblastoma in mice D Yuzhakova, E Kiseleva, M Shirmanova, V Shcheslavskiy, D Sachkova, ... Frontiers in Oncology 12, 1040637, 2022 | | 2022 |
